Insight Capital raring to splurge RMB500m on Chinese healthcare firms

It has finished fundraising for its third fund.

Beijing-based venture capital firm Insight Capital has collected US$71.89m (RMB500m) in capital commitments for its third fund, the company revealed in a statement.
The new fund will continue to target investment opportunities in the healthcare space in China. Limited partners in the new investment vehicle include government guidance funds, founders of pharmaceutical companies and domestic fund-of-funds.

Founded in 2016 and based in Beijing, Insight Capital is a venture capital firm focused on early-stage investment in China’s healthcare industry, investing across medical equipment, healthcare services, pharmaceutical research and development.

The firm has invested in over 30 companies, including Beijing-based biological material developer Aitekang Medical, Beijing-based autism recovery services platform Ingcare and online medical insurance claim portal jianbaolife.com.

With the completion of the new fund, Insight Capital has nearly RMB1 billion (US$144 million) under management.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit